SEC Filing Summary: Healthcare Trust, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Healthcare Trust, Inc. on April 6, 2023. The filing serves as a Regulation FD disclosure to distribute an investor presentation and a transcript of a conference call discussing the company's financial and operating results for the year and quarter ended December 31, 2022. The registrant is incorporated in Maryland and trades on The Nasdaq Global Market under symbols HTIA and HTIBP for its preferred stock series.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached exhibits (Exhibit 99.1 Investor Presentation and Exhibit 99.2 Transcript) which are furnished but not deemed "filed" for the purposes of Section 18 of the Exchange Act.
Material Changes
No material changes to financial results or operations are detailed within the body of this 8-K. The document acts solely as a conduit for the release of the previously mentioned presentation and transcript regarding the 2022 results.
Guidance, Outlook, and Risks
The filing includes a standard forward-looking statements disclaimer. Management highlights several risks and uncertainties that could cause actual results to differ materially from projections, including:
- The global COVID-19 pandemic and related containment actions.
- Geopolitical instability due to the military conflict between Russia and Ukraine, including sanctions and economic impacts.
- Inflationary conditions and higher interest rate environments.
- Risks detailed in the Risk Factors section of the Annual Report on Form 10-K filed on March 17, 2023.
The company explicitly states it undertakes no obligation to update or revise forward-looking statements unless required by law.
Investor Verification Checklist
- Verify the specific 2022 financial results (revenue, FFO, debt levels) by reviewing Exhibit 99.1 (Investor Presentation) and Exhibit 99.2 (Transcript) available on the company website.
- Confirm the status of the 7.375% Series A and 7.125% Series B preferred stock dividends and redemption terms.
- Review the March 17, 2023 Form 10-K for a comprehensive list of risk factors referenced in this filing.
- Monitor the company's website for the replay of the April 6, 2023 webcast for management commentary on the 2022 performance.